Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HYC 11395

Next Previous
Drug Profile

HYC 11395

Alternative Names: HYC-11395

Latest Information Update: 28 Mar 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Hefei Cosource Pharmaceutical
  • Class Antiplatelets; Cardiovascular therapies
  • Mechanism of Action GPIIb-IIIa antagonists; Platelet aggregation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Acute coronary syndromes

Most Recent Events

  • 28 Mar 2024 No recent reports of development identified for clinical-Phase-Unknown development in Acute coronary syndromes(Prevention) in China (Injection)
  • 16 Feb 2021 Clinical trials in Acute coronary syndromes (Prevention) in China (unspecified route) (Hefei Cosource Pharmaceuticals pipeline, February 2021)
  • 16 Jan 2016 Preclinical trials in Acute coronary syndromes (Prevention) in China(unspecified route) before January 2016 (Hefei Cosource Pharmaceuticals pipeline, February 2021)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top